Although sulfobromophthalein sodium (BSP, Bromsulphalein) has been used extensively for testing hepatic function since its introduction by Rosenthal and White in 1925 (1) , relatively little was learned regarding its transport and metabolism until recent years. Disappearance of BSP from the blood after intravenous administration of the dye involves a complicated process (2) . It is effected by the interrelated functions of hepatic uptake, storage, conjugation, and biliary excretion, each of which may be influenced by such dynamic factors as blood circulation and protein availability (3) . The precise role of extrahepatic metabolism (4) and the importance of the enterohepatic circulation (5) of BSP in the physiology of normal and of pathologic states have not yet been clearly established.
The rate of disappearance of BSP from the blood (fractional clearance or percentage disappearance rate, PDR) has been suggested as a more sensitive index of liver function than is the percentage of intravenously administered BSP retained after a specific time interval (6, 7). Barber-Riley, Goetzee, Richards, and Thomson (8) have shown that after a single intravenous dose of BSP, the disappearance curve can be expressed as two exponential terms from which the rate of transfer from plasma to liver and that from liver to bile may be calculated. The initial exponential portion of the disappearance curve for BSP is likely a reflection of the function of hepatic uptake, although extrahepatic and enterohepatic influences have not been entirely excluded.
In 1950 Brauer and Pessotti (9) discovered that a metabolic transformation of most of the * Submitted for publication December 23, 1963 ; accepted February 27, 1964. This investigation was supported in part by research grant AM-06908 from the National Institutes of Health.
BSP administered intravenously occurs in the liver. Workers in other laboratories subsequently confirmed the presence of this chemically altered BSP (10) (11) (12) . It has been generally agreed that conjugation of BSP occurs primarily with glutathione, although the amino acids, glycine, glutamic acid, and cysteine (the components of the peptide glutathione), may participate also. A recent suggestion has been that the measurement of BSP metabolites in the serum may serve to distinguish those situations in which the uptake or the conjugation of BSP is impaired from instances in which conjugation proceeds normally but "regurgitation" of the metabolites occurs (13) .
The concepts of hepatic storage (14) and maximal biliary transport (transfer maximum, Tm) (15) have received support from recent studies utilizing continuous-infusion technics with simultaneous bile collections in dog and man (16, 17) . With infusion of BSP at a rate calculated to maintain a steady level of BSP in the plasma, the quantity cleared by the liver during a given interval is assumed to be equal to the quantity of the substance injected into the blood during that same time. Combes, Wheeler, Childs, and Bradley (18) found that when a large priming dose of BSP was administered at the time that a constant infusion was started, the hepatic removal rate was much higher transiently than the Tm. This suggests a rapid initial movement of BSP into a "storage compartment." Maintenance of the maximal rate of biliary excretion during a period of decreasing plasma concentration suggests a release of BSP from hepatic storage to the bile. Thus the indication is that BSP accumulates in liver cells in some fixed gradient with respect to plasma and is transferred into bile by a rate-limited transport system (19) .
This report presents a profile of BSP trans-1409 port and metabolism in normal individuals and in patients with hepatic disorders in whom measurements reflecting hepatic uptake, storage, conjugation, and biliary excretion of BSP have been obtained.
Methods
Subjects. Thirty-three individuals with several types of hepatic disease were studied, and 19 subjects free of hepatic disorders served as controls. The control group included some who had peptic ulcer or functional complaints and some who were healthy volunteers; none had clinical or laboratory evidence of liver disease. Of the patients with hepatic disease, 12 had portal or postnecrotic cirrhosis, 16 had hepatic obstruction (6 intrahepatic, including 2 with primary biliary cirrhosis and 4 with drug cholestasis, and 10 extrahepatic), two had hemochromatosis (with cirrhosis), one had hemosiderosis (without cirrhosis), and one had polycystic disease of the liver. Serial measurements were made in a patient as he convalesced from viral hepatitis. The diagnosis in each case was established by liver biopsy or at operation.
Procedures. Values for three parameters were determined in conjunction with a single intravenous injection of BSP: 1) BSP retention in serum at 60 or 120 minutes or both, 2) percentage of serum BSP that was conjugated, and 3) fractional clearance (PDR) as a reflection of hepatic uptake of BSP. Two days later, values for three others were measured with the use of a continuous infusion of BSP: 4) maximal transport rate (Tm) for biliary excretion, 5) relative hepatic storage capacity (S), and 6) conjugated BSP in the serum.
Each subj ect went without breakfast before the tests and lay comfortably on a bed during the tests.
Single injection of BSP. After a control blood specimen was taken, 5 mg of BSP per kg of body weight was injected intravenously, emptying the syringe within 15 seconds. Blood samples were drawn from the opposite arm at 5-minute intervals during a period of (16) , The results were plotted on semilogarithmic graph paper, and the PDR was calculated from the BSP concentrations at 5, 10, and 15 minutes after the injection. In most instances, including those where hepatobiliary disease was involved, a straight line could be determined from a semilogarithmic plot of results from this 15-minute period. Beyond that period a straight line could not be determined often, and the PDR was found usually to decrease progressively with time.
Most serum specimens were submitted also to chromatographic analysis by the technic of Meltzer, Wheeler, and Cranston (12) for the determination of free and conjugated BSP using ascending paper chromatography with the solvent system n-butanol: glacial acetic acid After an initial blood sample had been obtained, BSP was infused intravenously at a carefully controlled constant drop rate for 1 hour. For individuals without hepatic disease this rate was about 0.30 mg per minute per kg body weight, whereas for those with hepatic disease the initial infusion rate was decreased to 0.15 mg per minute per kg so as not to produce excessively high levels of serum BSP during the course of the infusions. There were no untoward effects of the BSP administrations reported by any of the patients or observed. The infusion rates were changed for both groups to approximately 0.3 of the initial rate during the second hour and 0.6 during the third hour. The precise rates of infusion were calculated from measurements of BSP concentration and volume for the hour of infusion. During the last 30 minutes of each hour of infusion, four venous samples were drawn at 10-minute intervals from an indwelling needle in the arm opposite that used for the infusion. Blood samples were obtained rapidly and with a minimum of agitation in order to avoid visible hemolysis. BSP concentration was determined in all samples, and the percentage existing as conjugated dye was determined in most of the blood samples as described.
The theoretical hepatic removal rate (R) was calculated for each hour of infusion according to the formula developed by Wheeler, Epstein, Robinson, and Snell (19): R = I + PV (AP/AT), where I is infusion rate (milligrams per minute), PV is plasma volume (milliliters per 100), and AP/AT is the rate of change of plasma concentration (milligrams per 100 milliliters per minute). Plasma volume was measured by use of J131-labeled human serum albumin. The three values for R obtained during the three infusion periods were plotted as ordinates against the corresponding values of AP/AT as abscissas, and the best-fitting straight line through the three points was determined by the method of least squares. The theoretical Tm is then equal to the value of R for which AP/AT = 0, and S is equal to the slope of the line.
Results BSP retention in the serum at 60 minutes after a single intravenous injection of 5 mg per kg body weight in subjects free of hepatic disease is less than 5%, and measurement of BSP conjugates in the serum by paper chromatography is technically impractical when retention is that slight. Accordingly, among the control group this measurement could be made in only 4 subjects. Their 60-minute BSP retention ranged from 6 to 10%o, and they had no other clinical or laboratory evidence of hepatic disease. In these instances, only trace amounts of conjugated BSP were found in the serum. No when most of the serum BSP in all patients with hepatic disorders was in conjugated form, the mean percentages for the two subgroups were similar. Values of PDR, Tm, and S in the cirrhotic subgroup and the group with biliary obstruction were lower than those in the group free of hepatic disease. The higher values for the ratio S/Tm occurred with biliary obstruction (p < 0.05), suggesting a relatively greater decrease of Tm than S in these individuals. Low values for S/Tm occurred in both subgroups, however.
Two of 4 patients with intrahepatic cholestasis due to drugs had normal S with decreased biliary excretion. Two patients with hemochromatosis had normal values for S and Tm and normal 60-minute retention, but PDR was moderately decreased. In the subjects with polycystic liver and hemosiderosis, all parameters had values that were essentially normal.
The percentage of conjugated BSP in the total serum BSP during the course of continuous infusion of the dye at three different rates is shown in Table IV with biliary obstruction indicated that, during this time interval (60 to 120 minutes), the clearance of BSP from the blood of the cirrhotic subgroup proceeded at a faster rate than it did in the obstructed group or that there was less regurgitation in the cirrhotic subgroup. That the sera from individuals of both subgroups at 120 minutes contained similar proportions of conjugated BSP suggested that the function of time was of importance in BSP conjugation. Plaa, Sparkes, Abide, and Hunter (22), using an extraction procedure for the simultaneous estimation of free and conjugated BSP in the serum at 15, 30, and 45 minutes after a single intravenous injection of the dye, found four general types of abnormal patterns, but none was diagnostic for a specific type of hepatic disease. They found that "altered products of BSP" appeared quite rapidly and in high concentration during the first 15 minutes after BSP administra- Linear regression equations (y = a + bx), correlation coefficients (r), and probabilities of chance occurrence for these correlations (p) are indicated on the graph. Points on the graph represent mean values for all determinations made at the indicated time in each group of subjects (without hepatic disorders, portal and postnecrotic cirrhosis, and biliary obstruction). Rates of infusion during first (I) and third (III) infusion periods were greater than theoretical Tm; the rate during second period (II) was, in general, less than Tm. tion in normal subjects (23) . The A decrease in PDR with normal 45-minute BSP retention noted in subjects with hemochromatosis has been observed previously by Mendenhall and Leevy (24) . Diminution of Tm and S in our subjects with hepatic disease is similar to that found by Wheeler and co-workers (16) . That a better discrimination between patients with portal or postnecrotic cirrhosis and those with biliary obstruction could not be achieved by these measurements emphasizes the importance of dysfunction at the cellular and subcellular levels in all hepatobiliary disease. A better preservation of S values in patients with biliary obstruction might have been anticipated even though secondary hepatocellular damage at the ultramicroscopic (25) and enzymatic (26) levels is known to occur. The recent report of Preisig, Williams, Sweeting, and Bradley (27) seems to suggest that the S/Tm ratio might offer better differentiation of these conditions. The overlap of S/Tm values between our cases of obstruction and of cirrhosis suggests that accurate differentiation cannot be expected on this basis.
Recently, Castenfors and Hultman (28) recommended injecting a large single dose of BSP (20 mg per kg) intravenously so that theoretically the transport mechanism would be working at full capacity for 30 to 60 minutes. They suggested that such a technic is better than the 5-mg per kg dose for diagnosing mild liver disease and that by analysis of the blood disappearance curve an estimate of the Tm might be made without constant infusion.
We did not attempt to determine conjugating capacity under these circumstances.
Presumably the appearance of BSP conjugates in the serum during the course of constant infusion of the dye is a result of reflux from the liver to the bloodstream (29) . The percentage of conjugates in the serum during the course of continuous infusion seemed to be as much a function of time as of the functional status of the liver. The rate of appearance was greatest in those patients with extrahepatic obstruction; this suggests that the highest rate as well as the largest amount of reflux occurs in this group. (33) have proposed a concept of "reversible extraction" of BSP not necessarily by way of the lymph or enterohepatic circulation. They speculated upon a direct return of unconjugated BSP to the blood from the hepatic storage space, although they did suggest that reflux is partly in the form of metabolites.
Summary BSP transport and metabolism have been studied in 33 persons with hepatic disorders and 19 without. Single injections and continuous infusions of BSP were administered intravenously, and measurements reflecting hepatic uptake, relative storage capacity, conjugation, and maximal biliary excretion of BSP were obtained. We suggest that such determinations contribute to understanding of the pathophysiologic phenomena involved in certain hepatic disorders.
Hepatic uptake, relative storage capacity, and maximal biliary excretion of BSP are diminished in most hepatobiliary diseases whether primarily hepatocellular or obstructive. This finding supports the impression that disturbances of function at the cellular and subcellular levels occur after extrahepatic bile-duct obstruction. None of these parameters of BSP metabolism distinguished between intrahepatic and extrahepatic obstruction.
Determination of retained BSP and BSP conjugates at both 60 and 120 minutes after a single injection of the dye may be helpful in differentiating cirrhosis from obstructive jaundice. In patients with cirrhosis, BSP retention declined more sharply between the first and second hours after injection than in patients with obstructive jaundice. The percentage of serum BSP present in conjugated form 1 hour after injection was significantly less in patients with cirrhosis than in those with obstruction. In these two groups of patients, the percentage of conjugated BSP in the serum at 120 minutes was approximately equal.
The appearance of conjugated BSP in the serum during continuous infusion of the dye is related to time as well as to the nature of the pathophysiologic process.
